These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3300889)

  • 1. A laboratory method to evaluate formulation effects on the in vitro antimicrobial activity of topical creams and ointments.
    Love D; Kubey W; Holmes CJ
    Burns Incl Therm Inj; 1987 Jun; 13(3):204-7. PubMed ID: 3300889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo comparison of two silver sulfadiazine antimicrobial agents on burn wound infection.
    Velanovich V; Heggers JP; Robson MC; Zoellner SM; McHugh TP; Boertman J; Niu XT; Schileru R
    J Burn Care Rehabil; 1987; 8(5):381-3. PubMed ID: 3667664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC; Nathan P
    J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM; Fox CL
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
    Drake DJ; Froese EH
    Cent Afr J Med; 1975 Apr; 21(4):71-2. PubMed ID: 806345
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of topical therapy of the burn wound with silver sulphadiazine after its use for 15 years in a burn unit.
    Koo DS; Zhen S; Zhen ZD; Shi XW; Xiang SJ
    Burns; 1989 Jun; 15(3):193-6. PubMed ID: 2757770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and clinical use of silver sulfadiazine and related topical antimicrobial agents.
    Fox CL
    Pahlavi Med J; 1977 Jan; 8(1):45-64. PubMed ID: 834468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release and antimicrobial activity of silver sulphadiazine from different creams.
    van Saene JJ; Trooster JF; Meulenhoff AM; Lerk CF
    Burns Incl Therm Inj; 1987 Apr; 13(2):123-30. PubMed ID: 3107761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial creams for the treatment of burns in infants and toddlers.
    Kudlácková M
    Acta Chir Plast; 1988; 30(1):39-43. PubMed ID: 2455403
    [No Abstract]   [Full Text] [Related]  

  • 10. The human pharmacology of silver sulphadiazine (AgSD).
    Fox CL
    Burns Incl Therm Inj; 1985 Apr; 11(4):306-7. PubMed ID: 4005650
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns.
    Hosseini SV; Tanideh N; Kohanteb J; Ghodrati Z; Mehrabani D; Yarmohammadi H
    Int J Surg; 2007 Feb; 5(1):23-6. PubMed ID: 17386910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim.
    Lowbury EJ; Jackson DM; Ricketts CR; Davis B
    Injury; 1971 Jul; 3(1):18-24. PubMed ID: 5115151
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in anti-infective treatment of burn patients: a 3-year retrospective review.
    Knolle P
    Burns Incl Therm Inj; 1984 Oct; 11(1):54-8. PubMed ID: 6509352
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of topical dimethyl sulfoxide in burn wound infection: evaluation in the rat.
    Raskin DJ; Sullivan KH; Rappaport NH
    Ann N Y Acad Sci; 1983; 411():105-9. PubMed ID: 6576686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection.
    Fox CL; Rao TN; Azmeth R; Gandhi SS; Modak S
    J Burn Care Rehabil; 1990; 11(2):112-7. PubMed ID: 2335547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental animal studies of the healing of burn wounds with the use of local antimicrobials and hyperbaric O2 therapy].
    Kaiser W
    Z Exp Chir Transplant Kunstliche Organe; 1989; 22(1):27-37. PubMed ID: 2711716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
    Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
    J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds.
    Boekema BK; Pool L; Ulrich MM
    Burns; 2013 Jun; 39(4):754-9. PubMed ID: 23036845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Silver sulphadiazine cream in the treatment of chronic Pseudomonas infection of the external auditory canal in fifteen dogs (author's transl)].
    van den Bogaard AE; Maes JH; Simons HP
    Tijdschr Diergeneeskd; 1982 Mar; 107(6):224-8. PubMed ID: 6801814
    [No Abstract]   [Full Text] [Related]  

  • 20. The side effects of silver sulfadiazine.
    Fuller FW
    J Burn Care Res; 2009; 30(3):464-70. PubMed ID: 19349889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.